Bora CDMO Bora CDMO

X

Find RVU120 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

SEL120
Also known as: 1609452-30-3, Sel120, Sel-120, Se-120-34a, Sdm3m518pj, Sel120-34a (monohydrochloride)
Molecular Formula
C15H19Br2ClN4
Molecular Weight
450.6  g/mol
InChI Key
GQXLWUCQESKBSC-UHFFFAOYSA-N
FDA UNII
SDM3M518PJ

CDK8/19 Inhibitor SEL 120 is an orally bioavailable inhibitor of cyclin-dependent kinases 8 and 19 (CDK8/19), with potential antineoplastic and chemoprotective activities. Upon oral administration, CDK8/19 inhibitor SEL 120 targets, binds to and inhibits the activity of CDK8/19, which prevents activation of CDK8/19-mediated oncogenic signaling pathways, blocks selective transcription of various tumor-promoting genes, and inhibits proliferation of CDK8/19-overexpressing tumor cells. CDK8/19, serine/threonine kinases involved in the regulation of the cell cycle, are overexpressed in certain cancer cell types and play key roles in tumor cell proliferation.
1 2D Structure

SEL120

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6,7-dibromo-5-methyl-2-piperazin-1-yl-1,3-diazatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraene;hydrochloride
2.1.2 InChI
InChI=1S/C15H18Br2N4.ClH/c1-9-11(16)12(17)10-3-2-6-21-14(10)13(9)19-15(21)20-7-4-18-5-8-20;/h18H,2-8H2,1H3;1H
2.1.3 InChI Key
GQXLWUCQESKBSC-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C2C3=C(CCCN3C(=N2)N4CCNCC4)C(=C1Br)Br.Cl
2.2 Other Identifiers
2.2.1 UNII
SDM3M518PJ
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1609452-30-3

2. Sel120

3. Sel-120

4. Se-120-34a

5. Sdm3m518pj

6. Sel120-34a (monohydrochloride)

7. 1609452-30-3 (hcl)

8. 7,8-dibromo-9-methyl-2-piperazin-1-yl-5,6-dihydro-4h-imidazo[4,5,1-ij]quinoline Hydrochloride

9. 4h-imidazo(4,5,1-ij)quinoline, 7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-, Hydrochloride (1:1)

10. 7,8-dibromo-5,6-dihydro-9-methyl-2-(1-piperazinyl)-4himidazo(4,5,1-ij)quinoline Hydrochloride

11. Unii-sdm3m518pj

12. Chembl4578881

13. Schembl17106021

14. S8840

15. Akos037648926

16. Ex-a2929-1

17. Hy-111388a

18. 7,8-dibromo-9-methyl-2-(piperazin-1-yl)-5,6-dihydro-4h-imidazo[4,5,1-ij]quinoline Hydrochloride

19. Bs-16042

20. Imidazo[4,5,1-ij]quinoline Hydrochloride

21. Cs-0041061

22. A17086

23. D80736

24. Sel120(sel120-34,sel120-34a)

25. 7,8-dibromo-9-methyl-2-piperazin-1-yl-5,6-dihydro-4h-

26. Sel120-34a Monohydrochloride (1609522-33-9 Free Base)

27. 6,7-dibromo-5-methyl-2-piperazin-1-yl-1,3-diazatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraene;hydrochloride

2.4 Create Date
2014-05-26
3 Chemical and Physical Properties
Molecular Weight 450.6 g/mol
Molecular Formula C15H19Br2ClN4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass449.96445 g/mol
Monoisotopic Mass447.96650 g/mol
Topological Polar Surface Area33.1 Ų
Heavy Atom Count22
Formal Charge0
Complexity390
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY